Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study)
Title:
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study)
Author:
Aranda, E. Manzano, J.L. Rivera, F. Galán, M. Valladares-Ayerbes, M. Pericay, C. Safont, M.J. Mendez, M.J. Irigoyen, A. Arrivi, A. Sastre, J. Díaz-Rubio, E.